Barclays PLC Grows Holdings in Sangamo Therapeutics, Inc. (NASDAQ:SGMO)
Barclays PLC raised its position in shares of Sangamo Therapeutics, Inc. (NASDAQ:SGMO – Free Report) by 6,324,700.0% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 63,248 shares of the biopharmaceutical company’s stock after purchasing an additional 63,247 shares during the quarter. Barclays […]
Barclays PLC raised its position in shares of Sangamo Therapeutics, Inc. (NASDAQ:SGMO – Free Report) by 6,324,700.0% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 63,248 shares of the biopharmaceutical company’s stock after purchasing an additional 63,247 shares during the quarter. Barclays […]
